CYP11A1 and melanoma: Following our previous findings that CYP11A1-derived hydroxysecosteroids can inhibit proliferation of melanoma cell lines [49, 55], we selected 20(OH)D3 for further experimental testing on a SKMel-188 human melanoma line using established in vitro and in vivo assays of tumorigenesis and tumor progression.